
    
      Receiving immunosuppressants (azathioprine/6-MP/methotrexate) at Week 0 or not.

      604 patients will be enrolled with 1006 patients screened (to allow for 25% screen failures
      between screening and Week 0 and expected presentation at Screening of 60% of patients with
      CRP < 10 mg/L and 40% of patients with CRP â‰¥ 10 mg/L).
    
  